Michael Lidak is 7.5 % of the portfolio. It is acting a little negative here, I am in at 1.75 and would not wish to see it that low again.. but I think LIDAKOL will pass phase 3 and we will see higher prices in April.. on good news...of the testing..
I will do a six months thorough examination of the trade in the summer to evaluate future potencial.
You need to read the information more closely:
LIDAKOL is in phase 3 for HERPES and oral herpes... dual test due APRIL 97
--------------phase 2 for Kaposi's Sarcoma, Molluscum Contagiosum, ------------------------------------------ and Genital Herpes
--------------phase 1.5 for Shingles
--------------preclinical 1 for Hiv Prevention (during intercourse)
AS AN ANTI-INFLAMATORY INDICATOR
--------------phase 1.5 for Hypertropic scarring, burns, wound healing
R&D ---------for ophtalmic indicator, anti-fungal indications, -------------systemic anti viral
Then ....
LMI (Large Multivalent Immunogen)
Cancer Indications------phase 2 Melanoma
R&D Anti viral indicator, Ige receptor modulation, dendritic cell based vaccines, stem cell proliferation..
These are anti-cancer anti-viral products
but the major play appears to be LIDAKOL and its effectiveness with herpes both oral and genital and its other associated applications.
anyhow the stock appears poised to go higher in the
next 3 months... near term I don't know its retracing back a bit, you may get a chance to participate at your dream price soon.
Insider bought 10k shares in Oct-Nov..
accumulation is not strong but heading in the right direction..
strong cash position..
In the local Guru's model portfolio. (Bud (leedom san diego stock report))(619 622 0231) as a BUY.
What is not to like Michael?
luis |
